|
Press Releases |
|
|
|
Thursday, June 23, 2022 |
|
Malaysian Genomics Resource Centre to Offer Pioneering Holistic Renal Care via New Venture |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake in Aquahealth Sdn Bhd, a kidney dialysis operator, from Rinani Renal Berhad. more info >> |
|
Monday, June 13, 2022 |
|
Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being classified as an affected listed corporation effective 13 June 2022. more info >> |
|
Monday, May 23, 2022 |
|
Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022 |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group registered a 211.66% increase in revenue to RM5.08 million for the third quarter ended 31 March 2022 (3Q 2022) compared with revenue of RM1.63 million for the same quarter of the previous financial year. more info >> |
|
Thursday, April 28, 2022 |
|
Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara's Ramadhan Initiative |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara's (YSN) Ihya Ramadhan 2022 programme through a monetary donation to help those in need. more info >> |
|
Wednesday, April 6, 2022 |
|
Personalised Health Supplements Customised from Genetic Screening Results Offered on airasia Super App |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical company, is pleased to announce the launch of its genetic screening plus personalised health supplements solutions on the airasia Super App, the region's leading travel & lifestyle digital platform. more info >> |
|
Monday, April 4, 2022 |
|
Malaysian Genomics Resource Centre Berhad Awarded Covid-19 Surveillance Contract |
Malaysian Genomics Resource Centre Berhad ("Malaysian Genomics" or "the Group"), a leading genomics and biopharmaceutical specialist, was recently awarded a COVID-19 surveillance contract by the Institute for Medical Research ("IMR"), the biomedical research arm of the Ministry of Health ("MOH"). Malaysian Genomics is one of the private laboratories that IMR has engaged to outsource genome surveillance of SARS-CoV2. more info >> |
|
Thursday, February 17, 2022 |
|
Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad |
Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, is pleased to announce the entry of a new substantial shareholder, Bintai Kinden Corporation Berhad ("Bintai Kinden"), a specialist in mechanical and electrical engineering services to the construction sector, in the Group. more info >> |
|
Wednesday, February 16, 2022 |
|
Malaysian Genomics Resource Centre Berhad Records Significant Increase in Revenue of RM7.63 Million |
Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, today announced that it recorded revenue of RM7.63 million for the second quarter ended 31 December 2021 ("2Q FY2022"), a significant increase of RM7.49 million compared with revenue of RM0.14 million for the corresponding quarter of the previous year. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Approval in Principle (AiP) Acquired from Classification Society for Low-Pressure Type Coastal Liquefied CO2 Carrier
Feb 5, 2025 17:46 JST
|
|
|
富士通、世界最大のコネクティビティ関連展示会「MWC Barcelona 2025」に出展
Feb 5, 2025 14:30: JST
|
|
|
三菱造船、低圧液化CO₂内航輸送船の基本設計承認(AiP)を船級協会から取得
Feb 5, 2025 14:30: JST
|
|
|
トヨタ、米国ノースカロライナ州での車載用電池工場稼働開始
Feb 5, 2025 13:30: JST
|
|
|
トヨタ、上海市とカーボンニュートラルに関する包括的提携契約を締結
Feb 5, 2025 13:30: JST
|
|
|
トヨタ、2025年3月期 第3四半期決算を発表
Feb 5, 2025 13:30: JST
|
|
|
Toyota Powers On New North Carolina Automotive Battery Plant
Feb 5, 2025 13:59 JST
|
|
|
Toyota to Form Comprehensive Partnership on Carbon Neutrality with Shanghai and Establish a Company to Develop and Produce BEVs and Batteries
Feb 5, 2025 13:56 JST
|
|
|
Fujitsu to highlight AI-powered network technologies at MWC Barcelona 2025
Feb 5, 2025 10:25 JST
|
|
|
Mallia Therapeutics 與 Northway Biotech 宣布合作生產可溶性 CD83 蛋白 用於脫髮治療
Feb 5, 2025 08:00 HKT/SGT
|
|
|
KKR、富士ソフトに対する第2回公開買付価格を1株9,850円に引き上げ
Feb 4, 2025 23:00: JST
|
|
|
QSEC-CEE 2025 Concludes with Breakthroughs in Quantum Cybersecurity
Feb 4, 2025 21:00: JST
|
|
|
QSEC-CEE 2025 Concludes with Breakthroughs in Quantum Cybersecurity
Feb 4, 2025 20:00 HKT/SGT
|
|
|
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
Feb 4, 2025 18:00 HKT/SGT
|
|
|
TOYOTA GAZOO Racing Launches Evolved GR Corolla in Japan
Feb 4, 2025 18:41 JST
|
|
|
|
More News >> |
|
|
|
|
|